Page 68

Proefschrift binnenwerk Manon Ernst_DEF.indd

C H A P T E R   4   66       Figure  2:   Change  in  weight  for  height  (SDS),  after  1  year  of  rhGH  treatment,  plotted  against  the  change   in  TBW/  height2(l/m2),  6  weeks  after  the  start  of  rhGH  treatment.   Discussion   The  present  study  of  20  SGA  children  showed  a  change  in  TBW  after  six  weeks  of   treatment   with   rhGH   of   0.62   as   well   as   a   change   in   height   one   year   thereafter   of   0.81  SDS.  These  results  are  comparable  with  the  nationwide  Dutch  study  of  Ernst  et   al15  of  99  SGA  children  where  the  treatment  with  rhGH  of  SGA  children  results  in  a   change  of  the  TBW  with  0.68  SDS  after  six  weeks  and  an  increase  in  height,  one  year   after  rhGH  treatment  of  0.87  SDS.     SGA   children   are   treated   with   rhGH   primarily   to   repair   their   small   height.   At   the   same   time   monitoring   of   weight   in   relation   to   height   is   also   of   great   importance,   because  SGA  children  are  prone  to  increase  their  weight  outside  the  normal  range.   This   increase   must   be   prevented   to   reduce   the   risk   on   the   metabolic   syndrome,   which  origin  has  to  be  found  in  early  life,  as  stated  on  Barker’s  hypothesis21,22,23.   Morgan  et  al  supports  the  concept  that  genetic  factors  associated  with  obesity  and/   or  risk  of  type  2  diabetes  are  more  prevalent  in  those  born  SGA  compared  to  those   born  appropriate  for  gestational  age  (AGA)24.  Meas.  et  al  stated  that  being  born  SGA   affects   body   composition:   Adults,   born   SGA,   show   an   accelerated   gain   in   BMI   and   waist  circumference,  which  in  turn  results  in  higher  body  fat  content  with  a  central  


Proefschrift binnenwerk Manon Ernst_DEF.indd
To see the actual publication please follow the link above